How long does Wegovy 2.4mg stay in your system after a dose?

Why a seven-day half-life leads to roughly five weeks of clearance

Half-life describes the time it takes for the concentration of a medicine in your blood to fall by half. Semaglutide's half-life sits at around 165–184 hours, which rounds to approximately seven days. From that starting point, pharmacokinetic convention tells us that five half-lives are needed to eliminate a drug to below 3% of its peak, so after five consecutive weeks without an injection, the 2.4mg dose is effectively cleared. This is substantiated in the NHS semaglutide medicines page, which reflects the same pharmacokinetic basis used by UK prescribers.

The flip side is just as important. Because each weekly dose overlaps substantially with the last, semaglutide is still building up in your system for the first four to five weeks of treatment. Patients sometimes wonder why appetite suppression feels modest at 0.25mg or 0.5mg and strengthens over time, part of that is the accumulation effect as levels climb toward steady state, not just the dose step. If you are curious how the earlier dose steps compare, the 0.5mg dose clearance page covers the same principle at that stage of treatment.

None of this is reason for alarm. A long half-life also means that a single late injection rarely destabilises the effect dramatically, but your prescriber is the right person to advise on what to do if your schedule shifts.

What five weeks of clearance means for treatment breaks and holidays

Knowing that the 2.4mg dose lingers for roughly five weeks has real, practical implications. If you stop injecting for two or three weeks (say, over a long holiday, or because a pen arrived late around a bank holiday) meaningful concentrations of semaglutide are still present. Appetite may return progressively as levels fall, and some people notice weight regain beginning within those weeks, which aligns with what STEP 1 trial data showed about weight trajectories after treatment cessation.

On the other hand, a planned pause that runs longer than five weeks means you are essentially restarting. Whether that requires dose re-titration from a lower step is a clinical decision, not one to make based on a general guide. This is a question our prescribers hear often, particularly from patients thinking about pausing for surgery, the NHS England guidance on weight-management injections is clear that your surgical team and anaesthetist should know you are on a GLP-1 medicine before any procedure. The Wegovy dosage progression page gives more context on how the schedule is structured from start to maintenance.

If you take the tablet once a week on a fixed day (payday, a Monday, whichever anchor works for you) that predictability also makes it easier to notice when a dose is running late, which matters more at the 2.4mg stage than at earlier points because interruptions at maintenance have a cleaner impact to trace. If you have recently stepped up and want to understand how long 1mg Wegovy stays in your system, that page walks through the same clearance principles at the dose just below maintenance.

How long semaglutide remains detectable and what that means for specific situations

There are several circumstances where the clearance window becomes more than academic. Pregnancy is the clearest example. UK prescribing guidance advises discontinuing semaglutide at least two months before attempting to conceive, because detectable concentrations persist well beyond the final injection and the medicine is not recommended during pregnancy or breastfeeding. That two-month minimum reflects the five-week clearance time plus an additional margin of clinical caution. Anyone planning a family while on Wegovy should raise this with their prescriber well in advance. The full guide on how long semaglutide stays in the system after the last dose covers this and related situations in more depth.

Drug interactions are another context where clearance timing matters. Semaglutide slows gastric emptying, which can delay the absorption of other oral medicines taken at the same time. For oral contraceptives specifically, UK guidance recommends adding a barrier method for the first two months of Wegovy treatment while absorption patterns settle. Once cleared from the body, that interaction disappears, but while the medicine is active, the effect on gastric transit is real and worth discussing with whoever manages your other medications.

Finally, if you are switching from the injectable to the oral semaglutide tablet (now licensed in the UK as Wegovy tablets) your prescriber will factor in the clearance profile when timing the transition. You can read more about treatment options, including how oral and injectable semaglutide compare, on the weight-loss treatments page. Cost context, for those weighing up a sustained private prescription, is addressed on the Wegovy where to buy page.